QQ客服 官方微博 反馈留言

	Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value
	Lehmann, Brian David; Ding, Yan; Viox, Daniel Joseph; Jiang, Ming; Zheng, Yi; Liao, Wang; Chen, Xi; Xiang, Wei; Yi, Yajun
刊名	BMC CANCER
	2015
卷号	15
关键词	Breast cancer Gene expression profiles Signatures Meta-analysis Prognosis HER2-breast cancer Chemosensitivity
DOI	10.1186/s12885-015-1102-7
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4777231
专题	山东大学
作者单位	1.Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA. 2.Vanderbilt Univ, Dept Biostat, Nashville, TN 37235 USA.
推荐引用方式 GB/T 7714	Lehmann, Brian David,Ding, Yan,Viox, Daniel Joseph,et al. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value[J]. BMC CANCER,2015,15.
APA	Lehmann, Brian David.,Ding, Yan.,Viox, Daniel Joseph.,Jiang, Ming.,Zheng, Yi.,...&Yi, Yajun.(2015).Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.BMC CANCER,15.
MLA	Lehmann, Brian David,et al."Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value".BMC CANCER 15(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。